Table 1.
Patient features | Total | % |
---|---|---|
Median age at primary treatment (range), years | 63 (39–90) | |
Gender | ||
Male | 48 | 64 |
Female | 27 | 36 |
Median largest basal diameter (range), mm | 15.7 (5.9–26) | |
Median ultrasound height (range), mm | 8.4 (1.0–18.3) | |
Ciliary body involvement | ||
No | 51 | 68 |
Yes | 24 | 32 |
Extraocular melanoma | ||
No | 65 | 87 |
Yes | 10 | 13 |
Epithelioid cells present | ||
No | 40 | 53 |
Yes | 35 | 47 |
Closed PAS+ loops present | ||
No | 30 | 40 |
Yes | 45 | 60 |
Median mitotic count (range) | 4.0 (1–38) | |
Chromosome 1p | ||
Normal | 49 | 65 |
Loss | 18 | 24 |
Unclassified | 8 | 11 |
Chromosome 3 | ||
Normal | 35 | 47 |
Loss | 40 | 53 |
Chromosome 6p | ||
Normal | 48 | 64 |
Gain | 26 | 35 |
Unclassified | 1 | 1 |
Chromosome 6q | ||
Normal | 51 | 68 |
Loss | 13 | 17 |
Gain | 5 | 7 |
Unclassified | 6 | 8 |
Chromosome 8p | ||
Normal | 53 | 70 |
Loss | 11 | 15 |
Gain | 5 | 7 |
Unclassified | 6 | 8 |
Chromosome 8q | ||
Normal | 41 | 55 |
Gain | 34 | 45 |
Median follow‐up time (range), months | 70 (0–122) | |
Status | ||
Alive | 42 | 56 |
Dead | 33 | 44 |
Cause of death | ||
Metastatic melanoma | 17 | 52 |
Other | 6 | 18 |
Unknown | 10 | 30 |